Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 130
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #225: Q1 Lobbying Update; Individual vs. Group MDMA Therapy Study Launches; Australia Loosens Psychedelics Access Regulations; VA Launches “New” MDMA Trial
Three Brain Injuries, One Iboga Protocol, and What It Tells Us
The War on Drugs Was Never About Drugs. Psychedelic Healing Must Reckon With That.
A Dispatch from APA’s Annual Meeting: Psychedelics Return at an Awkward Moment for American Psychiatry
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race
Bright Minds Biosciences Announces Receipt of Nasdaq Notification Letter Regarding Minimum...
Doing Things Differently: Beyond Business as Usual in the Psychedelics Space
Adelaide Wilcox King: The Psychedelic Industry as a Catalyst for Reimagining...
Julia Mande: Consider the Conditions: Growing a Psychedelic Ecosystem
BetterLife Announces Engagement of Bloom Burton Securities Inc. and Provides Summary...
PT384 – Vital Psychedelic Conversations
Adapting to the Squeeze: Spending Trends, Slimming Pipelines, M&A and Partnerships...
Psychedelic Investor Pulse Survey – Q4 2022
MINDCURE Announces Financial Results for the Second Quarter of Fiscal 2023
Small Pharma Reports Fiscal Third Quarter 2023 Highlights
Load more